J&J to Pay as Much as $420 Million More in ASR Hip Accord

Updated on

Johnson & Johnson agreed to pay as much as $420 million more to resolve lawsuits over recalled hip implants that were excluded in 2013 from a $2.5 billion settlement of claims that the devices were defective and caused metal poisoning in patients.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.